Germany

BioNTech investigating packaging issue affecting Hong Kong, Macau

cde.news desk 24 March 2021, 14:00 · 1 min read

A sign announces the suspension of BioNTech vaccinations at a community vaccination center, in Hong Kong, China, 24 March 2021. Hong Kong halted the BioNTech Covid-19 vaccine rollout until further notice after the government received a notice from the vaccine supplier alerting of defective lids in a specific batch numbered 210102. EPA-EFE/JEROME FAVRE

Germany’s BioNTech said it was investigating a packaging issue in one production batch that has prompted a suspension of the use of its COVID-19 vaccine in Hong Kong and Macau.

Hong Kong and Macau authorities on Wednesday halted the use of the product, citing defective packaging.

BioNTech said on Wednesday the investigation is looking at the final production steps, including bottling into vials, known as fill and finish, re-packaging and handling at vaccination centers.

It added that no other regions had been supplied with the batch.

Main Photo: A sign announces the suspension of BioNTech vaccinations at a community vaccination center, in Hong Kong, China, 24 March 2021. EPA-EFE/JEROME FAVRE

Filed under Coronavirus Germany

Topics BioNTech

BioNTech investigating packaging issue affecting Hong Kong, Macau

More from Germany

What do we know about the wave of bomb threats against flights in Europe?

New wave of bomb threats hits passenger flights across Europe

Mysterious death of prominent German politician in Berlin hotel room